Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-216,861
Closed -$3.87M 51
2025
Q3
$3.87M Buy
+216,861
New +$3.15M 1.8% 26
2024
Q2
Sell
-43,442
Closed -$351K 50
2024
Q1
$351K Buy
+43,442
New +$389K 0.22% 46

Other funds holding AXGN

Roubaix Capital's AXGN Position: Q4 2025 in Review

Roubaix Capital sold out of Axogen (AXGN) in Q4 2025, closing a stake of 216,861 shares — an estimated $3.87M sold.

Roubaix Capital first reported a position in AXGN in Q1 2024 and held it in 2 quarters. The position peaked at $3.87M in Q3 2025. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

  • Roubaix Capital reported no remaining Axogen position as of Q4 2025 after selling out during the quarter.
  • Roubaix Capital sold 216,861 Axogen shares in Q4 2025, an estimated $3.87M.
  • Roubaix Capital first reported a position in Axogen in Q1 2024 and held it in 2 quarters.
  • Roubaix Capital's Axogen position peaked at $3.87M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on Roubaix Capital's 13F filing for Q4 2025, filed 9 Feb 2026.